Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Crossover Study of Patients With Heart Failure to Compare Natriuretic Effects of Immediate Release Torsemide vs. Extended Release Torsemide Over 12 Hours After Dosing

NCT06176794 is registered in ClinicalTrials.gov with Sarfez Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06176794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06176794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Crossover Study of Patients With Heart Failure to Compare Natriuretic Effects of Immediate Release Torsemide vs. Extended Release Torsemide Over 12 Hours After Dosing
Lead sponsor
Sarfez Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Withdrawn
Start date
November 15, 2024
Completion date
March 25, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure